Related Experiment Video
Updated: Jun 27, 2025

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Risk Assessment in Pulmonary Veno-Occlusive Disease: The First Step Towards Future Trials?
David Montani1, Athénaïs Boucly1, Olivier Sitbon1
1Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France; Institut National de la Santé et de la Recherche Scientifique, Unité Mixte de Recherche S_999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies», Faculté de Médecine de Bicêtre et Hôpital Marie Lannelongue, Le Plessis Robinson, France; Assistance Publique - Hôpitaux de Paris, Groupe Hospitalo-Universitaire Paris-Saclay, Hôpital Bicêtre, Département Médico-Universitaire "THORINNO", Service de Pneumologie et Soins Intensifs, Centre de Référence de l'Hypertension Pulmonaire PULMOTENSION, Le Kremlin-Bicêtre, France.
No abstract available in PubMed .
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...

